top of page

NEWS & MEDIA

Search

NBM Recognized in the Press for its Biotechnology to Cure Paraplegia

May 11, 2021
0 min read

Updated: May 21, 2021

Recent Posts

NBM Accepted in FDA'S Total Product Lifecycle Advisory Program

NBM Accepted in FDA'S Total Product Lifecycle Advisory Program

NBM Chosen among Top 10 European Tissue Engineering Companies

NBM Chosen among Top 10 European Tissue Engineering Companies

SPINEREP granted "Breakthrough Device Designation” by the U.S. Food and Drug Administration

SPINEREP granted "Breakthrough Device Designation” by the U.S. Food and Drug Administration

Comments

bottom of page